Literature DB >> 10570499

Loss of work productivity due to illness and medical treatment.

I M Cockburn1, H L Bailit, E R Berndt, S N Finkelstein.   

Abstract

We examined the effects on work productivity of treatment with antihistamines in a retrospective study using linked health claims data and daily work output records for a sample of nearly 6000 claims processors at a large insurance company, between 1993 and 1995. We explained the variation in work output depending on the subjects' demographic characteristics, their jobs, and whether they were treated with "sedating" versus "nonsedating" antihistamines for nasal allergies. Differences of up to 13% in productivity were found after the subjects took sedating or nonsedating antihistamines. The observed effect suggests substantial indirect economic costs, which up to now have been largely overlooked because work productivity has proved difficult to measure objectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570499     DOI: 10.1097/00043764-199911000-00005

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  23 in total

Review 1.  Work-related musculoskeletal disorders: design as a prevention strategy. A review.

Authors:  T Amell; S Kumar
Journal:  J Occup Rehabil       Date:  2001-12

Review 2.  The economic burden of allergic rhinitis: a critical evaluation of the literature.

Authors:  Shelby D Reed; Todd A Lee; Douglas C McCrory
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 3.  The safety and efficacy of desloratadine for the management of allergic disease.

Authors:  William E Berger
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 4.  Employee health and presenteeism: a systematic review.

Authors:  Alyssa B Schultz; Dee W Edington
Journal:  J Occup Rehabil       Date:  2007-07-25

Review 5.  The cost and impact of health conditions on presenteeism to employers: a review of the literature.

Authors:  Alyssa B Schultz; Chin-Yu Chen; Dee W Edington
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 6.  Applications and mechanisms of immunotherapy in allergic rhinitis and asthma.

Authors:  Jasper H Kappen; Stephen R Durham; Hans In 't Veen; Mohamed H Shamji
Journal:  Ther Adv Respir Dis       Date:  2016-09-27       Impact factor: 4.031

7.  Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model.

Authors:  Marc F Botteman; Ron J Ozminkowski; Shaohung Wang; Chris L Pashos; Kendyl Schaefer; Daniel J Foley
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 8.  Evidence-based treatment of allergic rhinitis.

Authors:  R Pawankar; W Fokkens
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.806

9.  Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis.

Authors:  Patrick W Sullivan; Sheryl L Follin; Michael B Nichol
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  Bidirectional link between upper and lower airways in patients with allergic rhinitis.

Authors:  A Bencova; E Rozborilova; M Antosova
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.